Clinical Effects of Hard and Soft Tissue Grafting With Dental Implants
The Clinical Effect of Simultaneous Grafting With Implant Placement Comparing Soft Tissue Grafting Alone to Combined Hard and Soft Tissue Grafting
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- Graduate Periodontics University of Louisville
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Have one edentulous site bordered by 2 teeth in maxillary sites from second premolar to second premolar (maxillary 4 to 13) to receive an implant with simultaneous grafting with an ADMG with or without BDX.
- Healthy persons at least 18 years old.
- Understands and has signed the informed consent.
Exclusion Criteria:
- Patients with uncontrolled diabetes, immune disease, or any systemic disease that significantly affects the periodontium.
- Previous head and neck radiation.
- Patients who have taken oral bisphosphonates for > 3 years or any IV bisphosphonates.
- Smokers (or other tobacco habits that might interfere with soft tissue healing).
- Patients who need prophylactic antibiotics prior to dental procedures.
- Patients with allergies to any medication or material used in the study, or that would adversely affect study procedures.
- Chemotherapy in the previous 12 months.
- Psychological problems that would interfere with treatment.
- Pregnant subjects will be excluded due to risk of miscarriage
Patients unable or unwilling to sign the informed consent.
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Dental Implant & ADMG
Dental implant placed with simultaneous grafting using one layer of ADMG
|
A dental implant will be placed and the buccal soft tissue will be grafted using ADMG .
|
|
Experimental: Dental implant & ADMG & BDX
Dental implant placed plus simultaneous grafting using ADMG with BDX
|
A dental implant will be placed and the buccal soft tissue will be grafted using ADMG .
Dental Implant will be placed with ADMG that covers the BDX
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Buccal soft tissue contour around dental implant
Time Frame: 3 months
|
Contour will be categorized as concave,flat or convex(subjective categories).
|
3 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Buccal soft tissue thickness around dental implants
Time Frame: 3 months
|
The thickness will be measured with an endodontic file using a rubber stopper(objective measure of tissue thickness by penetrating tissue and measuring thickness in millimeters (mm).
|
3 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Henry Greenwell, DMD, MSD, University of Louisville
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 18.0470
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.